We came across a bullish thesis on Harrow, Inc. on Make Money, Make Time’s Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.'s share was trading at $47.88 as of September 24th. HROW’s trailing and forward P/E were 9.64 and 51.55 respectively according to Yahoo Finance. Eli Lilly and Company (LLY) Diabetes Medication Successful in Children and Adolescents Harrow Pharmaceuticals (HROW) is a U.S.-based ophthalmology-focused pharmaceutical company he ...